Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > From the Equity Letter of Today

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Feb 21, 2021 3:35pm

236 Views

Post# 32622343

RE:RE:RE:RE:From the Equity Letter of Today

menoalittle wrote: At this point in time, I suspect the vast majority of both the stock and the warrants are in better (i.e., much more informed, savvy... and far more patient) hands. And with a possible rule change looming, the worm (as they say) may have turned. Time will tell...

She certainly is trading differently, and higher volume as well. :-)

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?